Spots Global Cancer Trial Database for uterine leiomyosarcoma
Every month we try and update this database with for uterine leiomyosarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma | NCT00390234 | Fallopian Tube ... Female Reproduc... Ovarian Carcino... Ovarian Sarcoma Recurrent Ovari... Recurrent Uteri... Stage III Ovari... Stage III Uteri... Stage IV Ovaria... Stage IV Uterin... Uterine Carcino... Uterine Leiomyo... | ziv-aflibercept | 18 Years - | National Cancer Institute (NCI) | |
| Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma | NCT00282087 | Leiomyosarcoma Uterine Neoplas... | gemcitabine, do... | 18 Years - | Sarcoma Alliance for Research through Collaboration | |
| Chemotherapy in Treating Patients With Sarcoma of the Uterus | NCT00005643 | Endometrial Can... Sarcoma | pegylated lipos... | 21 Years - | GOG Foundation | |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | NCT00002764 | Endometrial Can... Kidney Cancer Metastatic Canc... Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide conventional su... | 16 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma | NCT02249702 | Leiomyosarcoma | gemcitabine + d... trabectedin | 18 Years - | Mario Negri Institute for Pharmacological Research | |
| Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus | NCT00002459 | Endometrial Can... Sarcoma | radiation thera... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus | NCT00003316 | Sarcoma | gemcitabine hyd... | 18 Years - | GOG Foundation | |
| STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma | NCT00006357 | Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine... | imatinib mesyla... | 15 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma | NCT00004066 | Ovarian Cancer Sarcoma Small Intestine... | filgrastim docetaxel gemcitabine hyd... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma | NCT00053794 | Endometrial Can... Sarcoma | perifosine | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids | NCT06244251 | Uterine Fibroid Uterine Sarcoma Uterine Leiomyo... | TU-LESS MPLS | - | West China Second University Hospital | |
| BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | NCT00526149 | Breast Cancer Endometrial Can... Head and Neck C... Melanoma (Skin) Ovarian Cancer Sarcoma | BI 2536 high performanc... mass spectromet... pharmacological... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma | NCT00414076 | Leiomyosarcoma Uterine Neoplas... | Letrozole | 18 Years - | M.D. Anderson Cancer Center | |
| Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus | NCT00614835 | Uterine Leiomyo... Uterine Cancer | Docetaxel plus ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Pazopanib for Treating Uterine Leiomyosarcoma | NCT02378142 | Uterine Leiomyo... | Pazopanib | 18 Years - | GOG Foundation | |
| Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus | NCT00379145 | Sarcoma | trabectedin | 18 Years - 120 Years | GOG Foundation | |
| CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma | NCT04727242 | LMS - Leiomyosa... Uterine Leiomyo... | Gemcitabine Dacarbazine Cytoreductive S... Functional Asse... Computed Tomogr... Gadolinium | 18 Years - | Stanford University | |
| Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract | NCT00003334 | Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma | paclitaxel pegylated lipos... | - 120 Years | NYU Langone Health | |
| Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma | NCT00101127 | Sarcoma | filgrastim pegfilgrastim docetaxel gemcitabine hyd... | 18 Years - | GOG Foundation | |
| Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00003939 | Brain and Centr... Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine... | trabectedin | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00041236 | Sarcoma | exatecan mesyla... | 15 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Thalidomide in Treating Patients With Gynecologic Sarcomas | NCT00006005 | Endometrial Can... Sarcoma | thalidomide | - | National Cancer Institute (NCI) | |
| BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | NCT00526149 | Breast Cancer Endometrial Can... Head and Neck C... Melanoma (Skin) Ovarian Cancer Sarcoma | BI 2536 high performanc... mass spectromet... pharmacological... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract | NCT00003334 | Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma | paclitaxel pegylated lipos... | - 120 Years | NYU Langone Health | |
| Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus | NCT00033644 | Sarcoma | sargramostim cisplatin dacarbazine doxorubicin hyd... mitomycin C | 18 Years - | GOG Foundation | |
| Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma | NCT00033709 | Sarcoma | temozolomide thalidomide | 18 Years - | National Cancer Institute (NCI) | |
| Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus | NCT00614835 | Uterine Leiomyo... Uterine Cancer | Docetaxel plus ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus | NCT00378911 | Recurrent Uteri... Uterine Leiomyo... | sunitinib malat... | 18 Years - | National Cancer Institute (NCI) | |
| Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma | NCT00282087 | Leiomyosarcoma Uterine Neoplas... | gemcitabine, do... | 18 Years - | Sarcoma Alliance for Research through Collaboration | |
| Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00003939 | Brain and Centr... Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine... | trabectedin | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma | NCT04727242 | LMS - Leiomyosa... Uterine Leiomyo... | Gemcitabine Dacarbazine Cytoreductive S... Functional Asse... Computed Tomogr... Gadolinium | 18 Years - | Stanford University | |
| Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer | NCT01132547 | Cancer | cyproheptadine ... placebo | 2 Years - 21 Years | University of South Florida | |
| Pazopanib for Treating Uterine Leiomyosarcoma | NCT02378142 | Uterine Leiomyo... | Pazopanib | 18 Years - | GOG Foundation | |
| Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus | NCT00003316 | Sarcoma | gemcitabine hyd... | 18 Years - | GOG Foundation | |
| Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma | NCT00002641 | Endometrial Can... Kidney Cancer Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide isolated perfus... adjuvant therap... conventional su... radiation thera... | 16 Years - 69 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00041236 | Sarcoma | exatecan mesyla... | 15 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma | NCT00004066 | Ovarian Cancer Sarcoma Small Intestine... | filgrastim docetaxel gemcitabine hyd... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Chemotherapy in Treating Patients With Sarcoma of the Uterus | NCT00005643 | Endometrial Can... Sarcoma | pegylated lipos... | 21 Years - | GOG Foundation | |
| Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus | NCT00003054 | Sarcoma | paclitaxel | - 120 Years | GOG Foundation | |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | NCT00002764 | Endometrial Can... Kidney Cancer Metastatic Canc... Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide conventional su... | 16 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Letrozole in Uterine Leiomyosarcoma | NCT05649956 | Uterine Leiomyo... | Letrozole | 18 Years - | GOG Foundation | |
| Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma | NCT00227669 | Sarcoma | docetaxel gemcitabine hyd... | 18 Years - 120 Years | UNICANCER | |
| Thalidomide in Treating Patients With Gynecologic Sarcomas | NCT00006005 | Endometrial Can... Sarcoma | thalidomide | - | National Cancer Institute (NCI) | |
| Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus | NCT00614835 | Uterine Leiomyo... Uterine Cancer | Docetaxel plus ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus | NCT00033644 | Sarcoma | sargramostim cisplatin dacarbazine doxorubicin hyd... mitomycin C | 18 Years - | GOG Foundation | |
| Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma | NCT00245102 | Adult Angiosarc... Adult Epithelio... Adult Leiomyosa... Adult Malignant... Adult Neurofibr... Adult Synovial ... Ovarian Sarcoma Recurrent Adult... Recurrent Uteri... Stage III Adult... Stage III Uteri... Stage IV Adult ... Stage IV Uterin... Uterine Carcino... Uterine Leiomyo... | sorafenib tosyl... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
